drugset / Trial / NCT06608134

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee Osteoarthritis

NCT06608134 ↗

Phase 0 Recruiting 120 enrolled R3 Medical Research
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a Pilot Study which is randomized, prospective, open label, dose escalation, non-controlled evaluating safety and feasibility of intra-articular Wharton's Jelly (WJ) allograft will be evaluated in patients suffering with knee osteoarthritis. The participants will be randomized to one of three dosing treatment arms that will consist of one intra-articular knee injection containing either low dose, medium dose or high dose WJ allograft tissue.

Timeline

Start
2024-10-01
Primary completion
2028-10-01
Completion
2029-10-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Umbilical Cord Wharton's Jelly Allograft Unknown 2 ml Other
Comparator Umbilical Cord Wharton's Jelly Allograft Unknown 3 ml Other
Comparator Umbilical Cord Wharton's Jelly Allograft Unknown 4 ml Other

Indications